GLOBUS MEDICAL, INC. Research and Development Expense
GLOBUS MEDICAL, INC. (GMED) reported Research and Development Expense of $36.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- GLOBUS MEDICAL, INC. research and development expense for the quarter ending 2026-06-30 was $36.32M, a 9.09% decline year-over-year.
- GLOBUS MEDICAL, INC. research and development expense for the quarter ending 2026-03-31 was $36.51M, a 10.43% increase year-over-year.
- GLOBUS MEDICAL, INC. research and development expense for the quarter ending 2025-12-31 was $36.16M, a 8.25% increase year-over-year.
- GLOBUS MEDICAL, INC. research and development expense for the quarter ending 2025-09-30 was $38.07M, a 7.59% increase year-over-year.
- GLOBUS MEDICAL, INC. research and development expense for fiscal 2025 was $147.25M, a 10.08% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. research and development expense for fiscal 2024 was $163.75M, a 32.05% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. research and development expense for fiscal 2023 was $124.01M, a 69.84% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. research and development expense for fiscal 2022 was $73.02M, a 24.99% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $36.32M 10-Q · filed 2026-08-06 | $72.83M 10-Q · filed 2026-08-06 | $108.99M derived: sum of 3 quarters · filed 2026-08-06 | $147.06M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $36.51M 10-Q · filed 2026-05-07 | $72.67M derived: sum of 2 quarters · filed 2026-05-07 | $110.74M derived: sum of 3 quarters · filed 2026-05-07 | $150.69M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $36.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $74.23M derived: sum of 2 quarters · filed 2026-02-24 | $114.18M derived: sum of 3 quarters · filed 2026-08-06 | $147.25M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $38.07M 10-Q · filed 2025-11-06 | $78.02M derived: sum of 2 quarters · filed 2026-08-06 | $111.08M 10-Q · filed 2025-11-06 | $144.49M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $39.95M 10-Q · filed 2026-08-06 | $73.02M 10-Q · filed 2026-08-06 | $106.42M derived: sum of 3 quarters · filed 2026-08-06 | $141.80M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $33.06M 10-Q · filed 2026-05-07 | $66.47M derived: sum of 2 quarters · filed 2026-05-07 | $101.85M derived: sum of 3 quarters · filed 2026-05-07 | $139.55M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $33.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $68.79M derived: sum of 2 quarters · filed 2026-02-24 | $106.49M derived: sum of 3 quarters · filed 2026-02-24 | $163.75M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $35.38M 10-Q · filed 2025-11-06 | $73.08M derived: sum of 2 quarters · filed 2025-11-06 | $130.35M 10-Q · filed 2025-11-06 | $182.60M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $37.70M 10-Q · filed 2025-08-07 | $94.97M 10-Q · filed 2025-08-07 | $147.22M derived: sum of 3 quarters · filed 2026-02-24 | $176.55M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $57.27M 10-Q · filed 2025-05-08 | $109.52M derived: sum of 2 quarters · filed 2026-02-24 | $138.85M derived: sum of 3 quarters · filed 2026-02-24 | $160.20M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $52.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $81.58M derived: sum of 2 quarters · filed 2026-02-24 | $102.93M derived: sum of 3 quarters · filed 2026-02-24 | $124.01M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $29.33M 10-Q · filed 2024-11-05 | $50.68M derived: sum of 2 quarters · filed 2024-11-05 | $71.76M 10-Q · filed 2024-11-05 | $91.27M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $21.35M 10-Q · filed 2024-08-06 | $42.43M 10-Q · filed 2024-08-06 | $61.94M derived: sum of 3 quarters · filed 2025-02-20 | $80.64M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $21.08M 10-Q · filed 2024-05-07 | $40.59M derived: sum of 2 quarters · filed 2025-02-20 | $59.29M derived: sum of 3 quarters · filed 2025-02-20 | $76.69M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $38.21M derived: sum of 2 quarters · filed 2025-02-20 | $55.60M derived: sum of 3 quarters · filed 2025-02-20 | $73.02M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $18.70M 10-Q · filed 2023-11-07 | $36.10M derived: sum of 2 quarters · filed 2023-11-07 | $53.51M 10-Q · filed 2023-11-07 | $104.53M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $17.39M 10-Q · filed 2023-08-03 | $34.81M 10-Q · filed 2023-08-03 | $85.83M derived: sum of 3 quarters · filed 2024-02-21 | $101.68M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $17.41M 10-Q · filed 2023-05-04 | $68.43M derived: sum of 2 quarters · filed 2024-02-21 | $84.29M derived: sum of 3 quarters · filed 2024-02-21 | $99.83M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $66.88M derived: sum of 2 quarters · filed 2024-02-21 | $82.42M derived: sum of 3 quarters · filed 2024-02-21 | $97.35M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $15.85M 10-Q · filed 2022-11-08 | $31.40M derived: sum of 2 quarters · filed 2022-11-08 | $46.32M 10-Q · filed 2022-11-08 | $61.56M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $15.55M 10-Q · filed 2022-08-04 | $30.47M 10-Q · filed 2022-08-04 | $45.71M derived: sum of 3 quarters · filed 2023-02-21 | $60.13M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $14.92M 10-Q · filed 2022-05-10 | $30.16M derived: sum of 2 quarters · filed 2023-02-21 | $44.59M derived: sum of 3 quarters · filed 2023-02-21 | $84.04M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $15.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $29.66M derived: sum of 2 quarters · filed 2023-02-21 | $69.12M derived: sum of 3 quarters · filed 2023-02-21 | $84.52M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $14.42M 10-Q · filed 2021-11-04 | $53.88M derived: sum of 2 quarters · filed 2021-11-04 | $69.28M 10-Q · filed 2021-11-04 | $84.77M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $39.45M 10-Q · filed 2021-08-04 | $54.86M 10-Q · filed 2021-08-04 | $70.35M derived: sum of 3 quarters · filed 2022-02-17 | $84.86M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $15.40M 10-Q · filed 2021-05-04 | $30.90M derived: sum of 2 quarters · filed 2022-02-17 | $45.41M derived: sum of 3 quarters · filed 2022-02-17 | $61.15M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $30.00M derived: sum of 2 quarters · filed 2022-02-17 | $45.75M derived: sum of 3 quarters · filed 2022-02-17 | $60.07M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $14.51M 10-Q · filed 2020-10-28 | $30.25M derived: sum of 2 quarters · filed 2020-10-28 | $44.58M 10-Q · filed 2020-10-28 | $44.58M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $15.75M 10-Q · filed 2020-08-05 | $30.07M 10-Q · filed 2020-08-05 | $30.07M derived: sum of 3 quarters · filed 2021-02-17 | $45.60M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $14.32M 10-Q · filed 2020-05-07 | $14.32M derived: sum of 2 quarters · filed 2021-02-17 | $29.85M derived: sum of 3 quarters · filed 2021-02-17 | $43.37M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $15.53M derived: sum of 2 quarters · filed 2021-02-17 | $29.05M derived: sum of 3 quarters · filed 2021-02-17 | $55.50M 10-K · filed 2021-02-17 | ||||
| 2018-09-30 | $15.53M 10-Q · filed 2019-11-06 | $29.05M derived: sum of 2 quarters · filed 2019-11-06 | $55.50M 10-K · filed 2020-02-20 | $41.74M 10-Q · filed 2018-11-08 | $53.15M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $13.52M 10-Q · filed 2019-08-01 | $26.21M 10-Q · filed 2019-08-01 | $37.63M derived: sum of 3 quarters · filed 2020-03-02 | $48.51M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $12.69M 10-Q · filed 2019-05-02 | $24.10M derived: sum of 2 quarters · filed 2020-03-02 | $34.99M derived: sum of 3 quarters · filed 2020-03-02 | $45.70M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $11.41M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $22.30M derived: sum of 2 quarters · filed 2020-03-02 | $33.01M derived: sum of 3 quarters · filed 2020-03-02 | $43.68M 10-K/A · filed 2020-03-02 | ||||
| 2017-09-30 | $10.89M 10-Q · filed 2018-11-08 | $21.60M derived: sum of 2 quarters · filed 2018-11-08 | $32.27M 10-Q · filed 2018-11-08 | $45.91M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $10.71M 10-Q · filed 2018-08-02 | $21.38M 10-Q · filed 2018-08-02 | $35.02M derived: sum of 3 quarters · filed 2019-02-21 | $45.29M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | $10.67M 10-Q · filed 2018-05-03 | $24.31M derived: sum of 2 quarters · filed 2019-02-21 | $34.57M derived: sum of 3 quarters · filed 2019-02-21 | $45.17M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | $13.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $23.91M derived: sum of 2 quarters · filed 2019-02-21 | $34.50M derived: sum of 3 quarters · filed 2019-02-21 | $44.53M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | $10.27M 10-Q · filed 2017-11-09 | $20.86M derived: sum of 2 quarters · filed 2017-11-09 | $30.89M 10-Q · filed 2017-11-09 | $40.56M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $10.59M 10-Q · filed 2017-08-03 | $11.25M 10-Q · filed 2016-07-27 | $20.62M 10-Q · filed 2017-08-03 | $21.45M 10-Q · filed 2016-07-27 | $30.30M derived: sum of 3 quarters · filed 2018-02-22 | $39.55M derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | $10.03M 10-Q · filed 2017-05-04 | $10.20M 10-Q · filed 2016-05-04 | $19.70M derived: sum of 2 quarters · filed 2018-02-22 | $28.95M derived: sum of 3 quarters · filed 2018-02-22 | $38.03M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $18.92M derived: sum of 2 quarters · filed 2018-02-22 | $28.00M derived: sum of 3 quarters · filed 2018-02-22 | $36.31M 10-K · filed 2018-02-22 | $36.98M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $9.25M 10-Q · filed 2016-11-09 | $9.41M 10-Q · filed 2015-11-04 | $18.33M derived: sum of 2 quarters · filed 2016-11-09 | $26.64M 10-Q · filed 2016-11-09 | $27.15M 10-Q · filed 2015-11-04 | $34.87M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $9.08M 10-Q · filed 2016-07-27 | $17.74M 10-Q · filed 2016-07-27 | $25.62M derived: sum of 3 quarters · filed 2017-03-16 | $33.77M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $8.66M 10-Q · filed 2016-05-04 | $16.54M derived: sum of 2 quarters · filed 2017-03-16 | $24.68M derived: sum of 3 quarters · filed 2017-03-16 | $32.38M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $16.03M derived: sum of 2 quarters · filed 2017-03-16 | $23.72M derived: sum of 3 quarters · filed 2017-03-16 | $31.17M 10-K · filed 2017-03-16 | $31.69M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $8.15M 10-Q · filed 2015-11-04 | $15.84M derived: sum of 2 quarters · filed 2015-11-04 | $23.28M 10-Q · filed 2015-11-04 | $29.70M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $7.69M 10-Q · filed 2015-07-31 | $15.14M 10-Q · filed 2015-07-31 | $21.55M derived: sum of 3 quarters · filed 2016-02-29 | $28.12M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $7.44M 10-Q · filed 2015-05-05 | $13.86M derived: sum of 2 quarters · filed 2016-02-29 | $20.43M derived: sum of 3 quarters · filed 2016-02-29 | $27.47M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $12.99M derived: sum of 2 quarters · filed 2016-02-29 | $20.02M derived: sum of 3 quarters · filed 2016-02-29 | $26.87M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $6.57M 10-Q · filed 2014-10-31 | $13.61M derived: sum of 2 quarters · filed 2014-10-31 | $20.45M 10-Q · filed 2014-10-31 | $27.68M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $7.04M 10-Q · filed 2014-08-06 | $13.88M 10-Q · filed 2014-08-06 | $21.11M derived: sum of 3 quarters · filed 2015-02-26 | $28.13M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $6.85M 10-Q · filed 2014-04-30 | $14.07M derived: sum of 2 quarters · filed 2015-02-26 | $21.10M derived: sum of 3 quarters · filed 2015-02-26 | $28.04M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $14.25M derived: sum of 2 quarters · filed 2015-02-26 | $21.19M derived: sum of 3 quarters · filed 2015-02-26 | $27.93M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $7.02M 10-Q · filed 2013-10-31 | $13.96M derived: sum of 2 quarters · filed 2013-10-31 | $20.70M 10-Q · filed 2013-10-31 | $26.47M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $6.94M 10-Q · filed 2013-08-02 | $13.68M 10-Q · filed 2013-08-02 | $19.45M derived: sum of 3 quarters · filed 2014-03-14 | $25.36M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $6.74M 10-Q · filed 2013-05-03 | $12.51M derived: sum of 2 quarters · filed 2014-03-14 | $18.43M derived: sum of 3 quarters · filed 2014-03-14 | $24.16M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $11.69M derived: sum of 2 quarters · filed 2014-03-14 | $17.42M derived: sum of 3 quarters · filed 2014-03-14 | $23.46M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $5.92M 10-Q · filed 2012-11-02 | $11.65M derived: sum of 2 quarters · filed 2012-11-02 | $17.69M 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $5.74M 10-Q/A · filed 2012-09-19 | $11.78M 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $21.31M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |